Bryan Haynes of the Troutman Sanders Tobacco practice was recently quoted in The Atlantic article, “The FDA is Keeping New Cigarettes Off the Market“.
Haynes explains why tobacco companies believe this violates the obvious intent of the law. “Why would you have a 180-day review for a presumably more complex process, and not for a presumably streamlined process?” It’s a question the cigarette maker Lorillard has posed in a public petition to the FDA, requesting that the agency return to the practice of provisionally allowing new products onto the market until it can expedite its reviews. Haynes suggests the issue may be decided in court.
For questions and/or comments, please contact Bryan Haynes, at 804.697.1420 or by email.